These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 5106102)
21. [Comparative study of 2 drugs and a placebo in chronic schizophrenia]. Tetreault L Actual Pharmacol (Paris); 1969; 22():1-18. PubMed ID: 4927120 [No Abstract] [Full Text] [Related]
22. Evaluation of piperacetazine (Quide) injection in acute schizophrenics. Kiev A; Güclü B; Kulkarni AS Curr Ther Res Clin Exp; 1972 Jul; 14(7):376-80. PubMed ID: 4625517 [No Abstract] [Full Text] [Related]
23. Relationship between the hospital milieu and the response to phenothiazines in the treatment of schizophrenics. Klerman GL; Goldberg SG; Davis D Acta Psychiatr Belg; 1970 Nov; 70(6):716-29. PubMed ID: 4931261 [No Abstract] [Full Text] [Related]
24. Predictor patterns in the management of therapy-resistant schizophrenia. Holden JM; Hsu W; Itil TM; Keskiner A Dis Nerv Syst; 1971 Apr; 32(4):260-8. PubMed ID: 4397410 [No Abstract] [Full Text] [Related]
25. Changes in ward behaviour of severely disabled schizophrenic patients. Ekdawi MY Br J Psychiatry; 1966 Mar; 112(484):265-7. PubMed ID: 5939888 [No Abstract] [Full Text] [Related]
26. A comparative trial of oxypertine and chlorpromazine in the treatment of acute psychoses. Wadzisz FJ Curr Ther Res Clin Exp; 1969 Dec; 11(12):784-92. PubMed ID: 4984044 [No Abstract] [Full Text] [Related]
27. Drug treatment in schizophrenia. Ban TA Can Psychiatr Assoc J; 1971 Dec; 16(6):473-85. PubMed ID: 4947634 [No Abstract] [Full Text] [Related]
28. Clinical and heuristic value of clinical drug research. Park LC; Imboden JB J Nerv Ment Dis; 1970 Nov; 151(5):322-40. PubMed ID: 4920499 [No Abstract] [Full Text] [Related]
29. PHENOTHIAZINE REDUCTION AS A CAUSE OF REHOSPITALIZATION. GANTZ RS; BIRKETT DP Arch Gen Psychiatry; 1965 Jun; 12():586-8. PubMed ID: 14286887 [No Abstract] [Full Text] [Related]
30. Butaperazine (Repoise). Med Lett Drugs Ther; 1968 Nov; 10(22):89-90. PubMed ID: 4389275 [No Abstract] [Full Text] [Related]
31. Evaluation of a new antipsychotic agent. Butaperazine maleate (repoise maleate). JAMA; 1968 Dec; 206(10):2307-8. PubMed ID: 4386884 [No Abstract] [Full Text] [Related]
33. Changes in primary process expression in hospitalized schizophrenics treated with phenothiazines: two projective tasks compared. Ebert JN; Ewing JH; Rogers MH; Reynolds DJ J Genet Psychol; 1977 Mar; 130(1st Half):83-94. PubMed ID: 16082 [TBL] [Abstract][Full Text] [Related]
34. A trial of fluphenazine enanthate in chronic schizophrenia. Millar J; Daniel GR Br J Psychiatry; 1967 Dec; 113(505):1431-2. PubMed ID: 4865296 [No Abstract] [Full Text] [Related]
35. Efficacy of haloperidol in drug refractory patients. Ban TA; Lehmann HE Int J Neuropsychiatry; 1967 Aug; 3():Suppl 1:78-86. PubMed ID: 4383142 [No Abstract] [Full Text] [Related]
36. The management of white certified schizophrenic patients in the community of the Witwatersrand. Pearlman T S Afr Med J; 1970 Oct; 44(41):1181-2. PubMed ID: 5497512 [No Abstract] [Full Text] [Related]
37. Piperacetazine in chronic mental patients: clinical observations and new urine color test. Forrest FM; Forrest IS Curr Ther Res Clin Exp; 1972 Nov; 14(11):689-95. PubMed ID: 4629106 [No Abstract] [Full Text] [Related]
38. Mesoridazine versus chlorpromazine in acute schizophrenia: a double-blind investigation. Hamid TA; Wertz WJ Am J Psychiatry; 1973 Jun; 130(6):689-92. PubMed ID: 4573820 [No Abstract] [Full Text] [Related]
39. Mesoridazine (Serentil). Med Lett Drugs Ther; 1971 Jan; 13(1):4. PubMed ID: 5560077 [No Abstract] [Full Text] [Related]
40. Role of fluphenazine decanoate in lessening the burden of chronic schizophrenics on the community. Stevens BC Psychol Med; 1973 May; 3(2):141-58. PubMed ID: 4577254 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]